Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Chemoradiotherapy × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 8 Oropharyngeal Neoplasms 7 Rectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Head and Neck Neoplasms 5 Esophageal Neoplasms 4 Pancreatic Neoplasms 3 Hypopharyngeal Neoplasms 3 Glioblastoma 3 Stomach Neoplasms 2 Pathologic Complete Response 2 Nasopharyngeal Carcinoma 2 NSCLC 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Thymoma 1 Smoking Cessation 1 Smoking 1 Small Cell Lung Carcinoma 1 Sinonasal undifferentiated carcinoma 1 Sinonasal Squamous Cell Carcinoma 1 Resectable Esophageal Cancer 1 Rectal Malignant Neoplasms 1 Radiation Injuries 1

Interventions

pegaspargase 4 tislelizumab 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Tacrolimus 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Etoposide 2 Cyclophosphamide 2 Busulfan 2 Azacitidine 2 sugemalimab 1 selinexor 1 relatlimab 1 pembrolizumab 1 gemcitabine-oxaliplatin regimen 1 fludarabine 1 Vorinostat 1 Valganciclovir 1 Transplantation 1 Thiotepa 1 Therapeutics 1 Sirolimus 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 Methylprednisolone 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡